Updated Jul 16, 2026
KAPLAN GILLA has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.16M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | AVTX | Avalo Therapeutics, Inc. | M — Option exercise | 3.2K | — | |
| 2026-03-27 | TYRA | Tyra Biosciences, Inc. | D — Derivative transaction | 53.2K | $37.75 | $2.01M |
| 2026-03-27 | TYRA | Tyra Biosciences, Inc. | M — Option exercise | 53.2K | $2.25 | $120K |
| 2026-03-27 | TYRA | Tyra Biosciences, Inc. | S — Open-market sale | 14.3K | $36.97 | $529K |
| 2026-03-27 | TYRA | Tyra Biosciences, Inc. | M — Option exercise | 14.3K | $2.25 | $32K |
| 2025-06-17 | TYRA | Tyra Biosciences, Inc. | S — Open-market sale | 9.6K | $9.78 | $94K |
| 2025-06-17 | TYRA | Tyra Biosciences, Inc. | S — Open-market sale | 10 | $10.35 | $104 |
| 2025-06-12 | TYRA | Tyra Biosciences, Inc. | S — Open-market sale | 6.8K | $10.38 | $71K |
| 2025-06-12 | TYRA | Tyra Biosciences, Inc. | S — Open-market sale | 15.0K | $10.31 | $155K |
| 2025-06-12 | TYRA | Tyra Biosciences, Inc. | S — Open-market sale | 30.0K | $10.31 | $309K |
| 2025-03-28 | AVTX | Avalo Therapeutics, Inc. | M — Option exercise | 3.2K | — |
KAPLAN GILLA is a corporate insider — currently tracked as Insider of Avalo Therapeutics, Inc. (AVTX). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 6 open-market sales ($1.16M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live KAPLAN GILLA profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.